(11) Elena M Khvatova, Victor N Samartzev, Pavel P Zagoskin, Igor A Prudchenko, and Inessa I Mikhaleva (2003) Delta sleep inducing peptide (DSIP): effect on respiration activity in rat brain mitochondria and stress protective potency under experimental hypoxia Peptides, 2003 Feb, Volume 24 (Issue 2), Pages 307-11
Table 3 [i] AOR: adjusted odds ratio
Educational background: Semaglutide as a molecule was originally developed for type 2 diabetes by Novo Nordisk and is sold under the brand names Ozempic (for diabetes) and Wegovy (for chronic weight management, introduced for weight management in 2021)
doi:10.3389/fphar.2015.00286 130
The arrangement covers joint development of 22 shelf-stable peptide formulations, pharmaceutical-grade manufacturing, proprietary purity and potency test methods, and production of Vector's transdermal delivery devices